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Abstract 
Purpose: To determine the phenolic composition and antiproliferative activity of 16 different extracts 
(hexane, dichloromethane, methanol and water) obtained from Bellis perennis, Convolvulus galaticus, 
Trifolium pannonicum and Lysimachia vulgaris on human breast cancer (MCF-7) and human 
hepatocellular carcinoma (HepG2/C3A) cell lines. 
Methods: The aerial parts of the plants were successively extracted with hexane, dichloromethane, 
methanol and water using a Soxhlet apparatus. The phenolic content of the plants were determined by 
plants by high performance liquid chromatography (HPLC) while their antiproliferative activity was 
evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide, a yellow tetrazole (MTT) 
assay. 
Results: Among the tested extracts, the methanol extract of B. perennis showed the best anti-
proliferative activity against MCF-7 cell line with IC50 (inhibiting 50 % of cell growth) value of 71.6 µg/mL. 
Furthermore, the dichloromethane extract of C. galaticus showed the best anti-proliferative activity 
against HepG2/C3A cell line with IC50 of 57.3 µg/mL. The HPLC data for the plant extracts showed the 
presence of the following phenolic compounds: gallic acid monohydrate, caffeic acid, rutin hydrate, 
luteolin-7-O-β-D glucoside, kaempferol, myricetin, quercetin, coumarin and apigenin.  
Conclusion: The findings of this study indicate that there is some justification for the use of B. perennis 
and C. galaticus as traditional anticancer medicinal herbs.  
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Bellis perennis L. (common daisy) is a 
herbaceous perennial herb in the family 
Asteraceae [1]. Common daisy is known as a 
traditional wound herb [2,3] and it had been used 
for the treatment of bruises, broken bones [4], 
sore throat [5], headache [6], common cold [7], 
rheumatism, inflammation and infections of the 
upper respiratory tract in traditional medicine [8]. 
The main constituents are saponins [9,10], 
essential oils [11], phenolics [12,13]. Antibacterial 
[11], antifungal [11,14], antioxidant [8,11], wound 
healing activity [2], anxiolytic properties [15], in 
vitro regeneration protocol [13], antitumor activity  
[16] and cytotoxic activity against HL-60 human 
promyelocytic leukemia cells [17] of B. perennis 
has also been investigated.  
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Convolvulus galaticus Rostan ex Choisy (Grizzle 
bindweed) is an endemic, perennial herb in the 
family Convolvulaceae. Leaves and roots of C. 
galaticus have been used as chalogogue, 
laxative, antihelmintic and strongly purgative in 
traditional phytotherapy. Furthermore, its flowers 
are used in the relief of toothache [18,19]. 
Antibacterial [20,21], antitumor [21] and 
anticancer activities [22] of C. galaticus have 
been reported.  
 
Trifolium pannonicum Jacq. subsp. elongatum 
(Willd.) Zoh. (Hungarian clover) is an endemic 
perennial plant belonging to Fabaceae family. 
Trifolium spp. has been used in folk medicine for 
the treatment of skin conditions [21]. T. 
pannonicum contains triterpene saponins in the 
seeds and flavonoid glycosides in the aerial parts 
[23]. Antibacterial [20,21] and antioxidant [23] 
activities of T. pannonicum have been reported.  
 
Lysimachia vulgaris L. (yellow loosestrife) is a 
rhizomatous perennial herb in the family 
Primulaceae [24]. It has been used in the 
treatment of fever, ulcers, diarrhea, wounds and 
as an analgesic, expectorant and anti-
inflammatory agent since ancient time [19]. It is a 
convenient plant for phytopurification of 
wastewater [25]. It contains flavonoids, sterols, 
phenolic acids and tannins [26,27]. Podolak et al 
[27] reported that a benzoquinone pigment and 
triterpene saponosides from underground parts 
of yellow loosestrife had a cytotoxic activity in 
vitro against several cancer cell lines (human 
and mouse melanoma cells) and also inhibited 
the growth of Candida albicans strains. 
 
The present study aims, for the first time to the 
best of our knowledge, to evaluate the  anti-
proliferative properties of B. perennis, C. 
galaticus, T. pannonicum subsp. elongatum and 
L. vulgaris extracts (hexane, DCM, MeOH and 
water) against human hepotocellular carcinoma 
(HepG2/C3A) cell and human breast cancer 




Plant materials and preparation of extracts 
 
B. perennis, C. galaticus, and T. pannonicum 
Jacq. subsp. elongatum aerial parts were 
collected from Abant Izzet Baysal University 
Campus, Bolu/Turkey in 2013. L. vulgaris was 
collected from Abant Lake, Bolu/Turkey in 2013. 
Identification of the species was made by Arzu 
Ucar Turker using “Flora of Turkey and the East 
Aegean Islands” [24,28-29] and voucher 
specimens (Table 1) were deposited at the Abant 
Izzet Baysal University (AIBU) Herbarium, Bolu, 
Turkey. 
 
The air-dried (1 week) powdered plant parts of B. 
perennis, C. galaticus, T. pannonicum and L. 
vulgaris were successively extracted with hexane 
(at 65-70 oC), DCM (at 55-60 oC), MeOH (at 60 
oC) and water (at 80 oC) to achieve extraction of 
both non-polar compounds to polar compounds, 
using a Soxhlet apparatus for 24 h. The extracts 
were filtered and extraction solvents (hexane, 
DCM and MeOH) were evaporated under low 
pressure at a temperature not higher than 45 oC 
using rotary evaporator. Aqueous extracts were 
evaporated using a lyophilizator at -65 oC. Plant 
materials, brief extraction procedure, designation 
of studied extracts and yields are shown in Table 
1. 
 
Human cancer cell lines and culture 
conditions 
 
Human breast adenocarcinoma (MCF-7) and 
human hepatocellular carcinoma (HepG2/C3A) 
cell lines were obtained from the American Type 
Culture Collection (ATCC, Manassas, VA, USA). 
All cell lines were grown in Dulbecco’s minimum 
essential medium (DMEM) with Earle’s salts 
(Mediatech Cellgro, Herndon, USA). Culture 
medium was supplemented with 10 % fetal 
bovine serum (FBS; Hyclone, Logan, USA), a 
solution of vitamins, sodium pyruvate and non-
essential amino acids (all at 1:100 v/v dilution of 
supplied solutions), penicillin (100 I.U./mL) and 
streptomycin (100 µg/ mL) (Mediatech Cellgro, 
VA). Cells were cultured at 37 °C in a humidified 
environment containing 5 % CO2. 
 
Cell viability assay 
 
Exponentially growing cells were plated in 96-
well microplates (Costar , Corning Inc.) at a 
density of 10 × 103 cells per well in 100 µL of 
culture medium and were allowed to adhere for 
16 h before treatment. Increasing concentrations 
of each extract in DMSO (Sigma-Aldrich) were 
then added (100 µL per well) and the cells were 
incubated for 24 h. The final concentration of 
DMSO in the culture medium was maintained at 
0.5 % (v/v) to avoid solvent toxicity. Cytotoxicity 
was assessed using 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl-tetrazolium bromide, a yellow 
tetrazole (MTT) assay [30] on an automated 96-
well Multiskan FC micro plate photometer reader 
(Thermo Fisher Scientific Inc.) at 570 nm. The 
proliferation test is based on the color reaction of 
mitochondrial dehydrogenase in living cells by 
MTT. The culture medium was removed and 
replaced with 90 µL of fresh culture medium. Ten 
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microlitres of sterile filtered MTT solution (5 
mg/mL) in phosphate buffered saline (PBS, pH 
7.4) were added to each well, reaching a final 
concentration of 0.5 mg MTT/ ml which was then 
incubated at 37 ˚C in 5 % CO2 for 4 h. After 4 h, 
100 µl/well of DMSO were added to all samples 
for dissolving the formazan that is the final 
product of MTT reaction and were allowed to 
incubate at 37 °C, in a 5 % CO2 humidified 
incubator for a night. After incubation, 
absorbance of formazan was measured 
spectrophotometrically in a Multiskan FC 
microplate photometer reader at 570 nm. Each 
experiment was carried out three times in 
triplicate. The relative cell viability (%) relative to 
control wells containing cell culture medium 
without samples was calculated as:  
 
Relative cell viability = 100 × A570 nm (sample) / 
A570 nm (control) 
 
HPLC analysis of phenolic compounds 
 
The DCM and methanolic extracts were analyzed 
using a HPLC system (VWR-Hitachi LaChrom 
Elite®) equipped with a Hitachi L-2455 Diode-
Array Detector (DAD), Hitachi L-2130 Pump, 
Hitachi L-2200 Autosampler. Chromatographic 
separation was achieved using Hitachi column 
oven L-2300 and Venusil XBP C18 column 
(Bonna-Agela Technologies, particle size 5 µm, 
4.6 x 250 mm). Flow rate was 1 ml/min with 25 
ºC oven and injection volume was 20 µL. All 
solvents were HPLC grade (Merck) and mobile 
phase was composed of solvent A (acetronitrile) 
and solvent B (0.1 % acetic acid). A gradient 
elution was performed. Mobile phases and 
ultrapure water (SG Labostar) were filtered 
through a 0.45 µm hydrophilic polypropylene 
membrane filter (47 mm) (Pall Corporation) prior 
to HPLC injection. Spectra data were recorded 
from to 200 to 400 nm during the entire run. The 
chromatograms were obtained at 280 nm. 
 
Sample preparation for HPLC analysis 
 
Dried DCM and MeOH extracts (100 mg) were 
dissolved in 1 ml ACETRONITRILE. All 
standards (gallic acid monohydrate, caffeic acid, 
rutin hydrate, luteolin-7-O-β-D glucoside, 
kaempferol, myricetin, quercetin, coumarin and 
apigenin) were prepared at 1 mg/ml in 
ACETRONITRILE and mixed together to make 
five different concentrations (1, 5, 10, 20, 40, 60, 
80 and 100 mg/L) for the preparation of standard 
curve. All extracts and standards were filtered 
through a 0.2-µm GHP Acrodisc (25 mm) (Pall 
Corporation) into 2-mL HPLC vials. Procedures 
were repeated 3 times for each sample tested. 
 
Statistical analysis  
 
All data were analyzed by analysis of variance 
(ANOVA) with the last factor as a within subject 
or repeated design using SPSS version 15 
(SPSS Inc., Chicago, IL, USA). Values were 
considered statistically significant at p ≤ 0.05. 
The data are presented as mean ± standard 





The cytotoxic effects of the 16 crude extracts 
(hexane, dichloromethane, methanol and water) 
of B. perennis, C. galaticus, T. pannonicum and 
L. vulgaris at various concentrations were 
evaluated with in vitro cytotoxicity assay against 
MCF-7 and HepG2/C3A cell lines (Table 1). 
Percentage of the cell viability was measured by 
MTT assay (Figures 1 and 2). A plant extract is 
usually regarded as interesting for in vitro 
cytotoxic activity if IC50 < 100 µg/ml [31]. 
 
The cytotoxic effects of all extracts against MCF-
7 and HepG2/C3A cells were shown in Table 1. 
Among the tested extracts, the methanolic 
extract of B. perennis showed the best 
antiproliferative activity against MCF-7 cell line 
with IC50 value of 71.6 µg/mL. The aqueous 
extracts of B. perennis showed a moderate 
antiproliferative activity against MCF-7 cells, with 
the IC50 value of 147.6 µg/mL. Meanwhile, DCM 
extract of C. galaticus showed also a moderate 
anti-proliferative activity against MCF-7 cell line, 
with the IC50 value of 172.4 µg/mL (Table 1).  
 
Among the tested extracts, the DCM extract of C. 
galaticus showed the best anti-proliferative 
activity against HepG2/C3A cell line with IC50 
value of 57.3 µg/mL. Furthermore, MeOH 
extracts of B. perennis and C. galaticus showed 
high anti-proliferative activity against 
HepG2/C3A, with IC50 value of 73.9 and 75.4 
µg/ml, respectively. 
 
Other tested plant extracts did not show any 
antiproliferative activity against MCF-7 and 
HepG2/C3A cell lines at all concentrations tested 
(Table 1). The shape of dose-response curves 
indicated a significant inhibition of cell growth in a 
dose-dependent manner (Figures 1 and 2). 
 
In the present study, quantification of the chosen 
phenolics in B. perennis, C. galaticus, T. 
pannonicum and L. vulgaris was performed using 
the HPLC technique.  
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Table 1: In vitro anti-proliferative effect of studied plants on MCF-7 and HepG2/C3A cell lines 
 
Family and Plants Species Collection Number Parts Used Solvents Designation Yield (%)* MCF-7 HepG2/C3A
Asteraceae
Hexane BH 3.9 > 200 > 200
DCM BD 2.5 > 200 184.7 ± 1.2
MeOH BM 29.9 71.6 ± 2.0 73.9 ± 3.0
Water BW 21.8 147.6 ± 4.0 154.2 ± 0.7
Convolvulaceae
Hexane CH 1.7 > 200 166.9 ± 0.2
DCM CD 5.2 172.4 ± 0.5 57.3 ± 0.9
MeOH CM 11.7 > 200 75.4 ± 1.5
Water CW 5.7 > 200 > 200
Fabaceae
Hexane TH 0.9 > 200 > 200
DCM TD 1.5 > 200 > 200
MeOH TM 7.1 > 200 > 200
Water TW 10.9 > 200 > 200
Primulaceae
Hexane LH 2.1 > 200 > 200
DCM LD 3.4 > 200 > 200
MeOH LM 10.3 > 200 > 200
Water LW 2.9 > 200 > 200
    Bellis perennis L. 
Trifolium pannonicum  Jacq.  
subsp. elongatum  (Willd.) Zohary 
Convolvulus galaticus  Rostan ex 
Choisy











Note: Mean values (±standard deviation) for triplicate assays. IC50: Concentration of extract that cause 50% 






























Fig. 1: Dose-response curves of the effect of BM, BW and CD extracts on cell growth in MCF-7 cells. Cells were 
treated with various concentrations (6.25, 12.5, 25, 50, 100 and 200 µg/mL) of extracts, after 24 h of exposure. 
Antiproliferative effects were measured by MTT assay. Results were expressed as mean ± SD (n = 3) 
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Fig. 2: Dose-response curves of the effects of BM, CD and CM extracts on cell growth in HepG2/C3A cells. Cells 
were treated with various concentrations (12.5, 25, 50, 100, 200 and 400 µg/mL) of extracts, after 24 h of 
exposure. Antiproliferative effects were measured by MTT assay. Results were expressed as mean ± SD for 
three independent determinations 
 
The MeOH extract of L. vulgaris contained the 
highest total phenolic compounds (40632.4 µg/g 
dry extract) (Table 2) while the DCM extract of C. 
galaticus contained the lowest total phenolic 
compounds (339.36 µg/g dry extract). 
Considerable amounts of quercetin (12517.02 
µg/g dry extract) and apigenin (512.54 µg/g dry 
extract) were found in B. perennis extracts. The 
most dominant were rutin hydrate and luteolin-7-
O-β-D glucoside in C. galaticus, T. pannonicum 




A high number of new natural drugs derived from 
plant secondary metabolites have been used in 
the treatment and/or prevention of cancer [32]. 
Since 1990, there has been a 22 % increase in 
cancer incidence and mortality, with over 10 
million new cases [32]. Important progress has 
been made in cancer chemotherapy, a 
considerable portion of which can be attributed to 
plant-derived drugs [32]. B. perennis has been 
used as a medicinal herb against cancer, breast 
cancer and uterine cancer [34]. In the literature, 
some saponins isolated from the root of B. 
perennis were found to be cytotoxic against only 
human promyelocytic leukemia (HL-60) cells 
[17]. However, no anticancer activity has been 
shown for flower extracts of B. perennis. 
Although there are some studies indicating the 
biological activities of B. perennis flower extracts, 
there is no study on the anticancer activity of this 
species. We therefore aimed to evaluate the 
anticancer activity of B. perennis by MTT assay 
on human breast adenocarcinoma (MCF-7) and 
human hepatocellular carcinoma (HepG2/C3A).  
 
Generally, methanol extracts were more active 
on MCF-7 cell line. Methanol extracts of plant 
materials may contain active components such 
as tannins, polyphenols, polyacetylenes, 
flavonol, terpenoids, and flavonoids [35]. In the 
present study, TLC plates also showed that 
methanolic extracts contained more phenolic and 
saponin compounds qualitatively than other 
tested extracts of B. perennis (data not shown). 
Natural products have been shown to be an 
excellent and reliable source for the development 
of new drugs [36]. Saponins are well known 
compounds in B. perennis and they have 
anticancer activity against human promyelocytic 
leukemia (HL-60) cells [17]. In the present study, 
TLC results showed that MeOH extracts of 
flowers of B. perennis have more phenolic 
compounds and saponins than other extracts, 
(data not shown). Thus, in our present study, the 
high levels of anticancer activity of MeOH 
extracts of B. perennis may be attributed to this 
high saponin and phenolic contents. Extracts of 
B. perennis flowers have anticancer activity 
against the human breast adenocarcinoma 
(MCF-7) and human hepatocellular carcinoma 
(HepG2/C3A) cell lines. Altogether, these results 
support the traditional use of B. perennis in the 
treatment of cancer. 
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Name Peak numbera RT (min) BD BM CD CM TD TM LD LM
Gallic acid monohydrate 1 4.7 10.88±0.1 11.64±0.05 38.12±0.03 133.01±0.01 8.4±0.02 80.5±0.04 41.64±0.02 139.0±0.1
Caffeic acid 2 10.65 47.06±0.07 95.82±0.1 34.0±0.01 306.0±0.01  4.0±0.01 189.0±0.01 83.0±0.02 75.0±0.01
Rutin hydrate 3 11.92 244.62±0.01 3239.12±0.02 47.67±0.01 2772.4±0.05  6.73±0.01 1285.4±0.5 2613.0±0.4 29024.0±0.7
Luteolin-7-O-β-D glucoside 4 12.52 63.64±0.07 - 8.29±0.02 1003.4±0.2 20.4±0.02 20959.4±0.9 244.7±0.1 8930.0±0.3
Kaempferol 5 12.7 147.8±0.1 3241.94±0.01 4.16±0.03  521.1±0.1 37.63±0.01 73.5±0.01 287.0±0.01 437.0±0.02
Myricetin 6 14.1 67.42±0.05 86.04±0.01 68.21±0.01 ≤ 0.001 ≤ 0.001 4680.1±0.7 145.0±0.02 605.0±0.1
Quercetin 7 15.76 340.52±0.02 12517.02±0.01 28.73±0.02 329.5±0.02 85.85±0.2 3407.9±0.2 1153.0±0.6 958.0±0.05 
Coumarin 8 16.68 1.34±0.01 - 51.37±0.01 91.0±0.1 282.2±0.01 ≤ 0.001 ≤ 0.001 ≤ 0.001
Apigenin 9 17.05 512.54±0.02 353.7±0.05 58.8±0.5 112.8±0.01 ≤ 0.001 318.3±0.09 ≤ 0.001 453.1±0.02
Total Phenolics 1435.82 19545.38 339.36 5136.0 445.06 30993.8 4566.54 40632.4
PLANT EXTRACTSb (µg/g dry extract)
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 Although Tokgun et al [22] reported the 
strongest anti-proliferative activity in methanolic 
extract of C. galaticus against MCF-7 cell line at 
low concentration (0.32 mu g/mL), we found that 
the methanolic extract did not have a notable 
anti-proliferative activity against MCF-7 cell line. 
But DCM extract of C. galaticus had a moderate 
anti-proliferative activity against MCF-7 cell line 
in our study. The differences in these two studies 
may have arisen from plant extraction procedure. 
Furthermore, we are the first to report that DCM 
and methanol extracts of C. galaticus have 
antiproliferative activity against HepG2/C3A cell 
lines. 
 
Podolak et al [27] showed the anticancer activity 
of L. vulgaris on human and mouse melanoma 
cells, however, we could not find the same 
activity against MCF-7 and HepG2/C3A cancer 
cells in our present study. The results of all 
studies indicated that different parts of plants had 
different levels of biological activity and phenolic 
compounds depending on the type of solvent 
used in the extraction procedure. The most 
important human diseases such as cancer, 
neurodegenerative and cardiovascular diseases 
are the result of free radicals.  
 
Phenolics are that antioxidant compounds that 
are widely found in natural environments and 
inhibit free radical formation [37]. Because of this 
reason, we investigated the nine phenolic 
compositions (gallic acid monohydrate, caffeic 
acid, rutin hydrate, luteolin-7-O-β-D glucoside, 
kaempferol, myricetin, quercetin, coumarin and 
apigenin) of tested extracts by HPLC analysis. 
The phenolic profiles of C. galaticus and T. 
pannonicum were detected for the first time and 
all tested standart phenolic compounds were 
found in both species. Toth et al [37] showed that 
polyphenol composition of three Lysimachia 
species. They similarly detected caffeic acid, 
chlorogenic acid, myricetin, isorhamnetin, 
quercetin and kaempferol in L. vulgaris. 
However, gallic acid, rutin hydrate, luteolin-7-O-
β-D glucoside and apigenin in L. vulgaris were 
demonstrated for the first time with our present 
study. It has been previously shown that phenolic 
constituents of B. perennis include flavonoids 
[13,38], anthocyanins [39] and phenolic acids 
(caffeic, ferulic, sinapic, p-coumaric, and salicylic 
acids) [40].  
 
The following flavonoids were described in daisy 
flowers: quercetin, apigenin, kaempferol and 
isorhamnetin [38]. In the present study, some 
phenolic compounds such as coumarin, luteolin-
7-O-β-D glucoside, myricetin and rutin hydrate 
were determined in flowers of B. perennis for the 
first time by HPLC analysis. 
CONCLUSION 
 
Our findings demonstrated that methanol extract 
of B. perennis flowers has anti-proliferative effect 
both on human breast cancer (MCF-7) and 
human hepatocellular carcinoma (HepG2/C3A) 
cancer cells. In addition, the methanolic and 
DCM extracts of C. galaticus have anti-
proliferative effects on HepG2/C3A cell line. With 
this study, B. perennis and C. galaticus gained 
scientific justification as anticancer medicinal 
herbs. Anticancer activities of C. galaticus 
against HepG2/C3A and B. perennis against 
MCF-7 and HepG2/C3A cancer cell lines were 
revealed for the first time. Furthermore, 
anticancer activities of aerial parts of L. vulgaris 
and T. pannonicum on human breast cancer 
(MCF-7) and human hepatocellular carcinoma 
(HepG2/C3A) were evaluated for the first time. 
Unfortunately, these plant extracts were not 
active to selected cancer cell lines in this study. 
Future studies should be focused on fractionation 
of the active plant extracts to identify active 
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